ÂÜÀòÂÒÂ×

Alyssa Schwartz-Haig, MS, RAC, serves as the Director of Regulatory Quality and Clinical at Carestream since July 2024, bringing extensive experience in regulatory compliance and quality assurance within the medical device and cosmetic industries. Previously, Alyssa held senior leadership roles at Oriel STAT A MATRIX and A Schwartz-Haig Consulting, focusing on quality and regulatory consulting to enhance compliance with FDA and global regulations. With a robust background that includes roles at Trice Medical, Zimmer Biomet, Flower Orthopedics, PhotoMedex, Neuronetics, DSM, and Thermo Fisher Scientific, Alyssa has a proven track record in rehabilitating quality systems, managing regulatory submissions, and overseeing compliance audits. Educational qualifications include a Master of Science in Bioscience Regulatory Affairs from Johns Hopkins University and a Bachelor of Science in Microbiology from the University of Pittsburgh.